Macrophage-targeted photodynamic therapy: Scavenger receptor expression and activation state

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 391-402

  Liu, Q ^a,b   Hamblin, Michael R ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Interferon gamma; Lipopolysaccharide; Macrophages; Photodynamic therapy; Photosensitizer conjugate; Scavenger receptor; Tumor necrosis factor alpha

Indexed keywords

BOVINE SERUM ALBUMIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PHOTOSENSITIZING AGENT; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL LINE; CELL PROTECTION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TARGET CELL;

EID: 27444439964     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800301     Document Type: Article

References (44)

1. Parthasarathy S., D. Steinberg and J.L. Witztum. 1992. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:219.
2. Cassells W., B. Hathorn, M. David, T. Krabach, W.K. Vaughn, H.A. McAllister, G. Bearman and J.T. Willerson. 1996. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 347:1447.
3. Falk E. 1992. Why do plaques rupture? Circulation 86: III30.
4. Mantovani A. 1994. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 71:5.
5. Wahl L.M. and H.K. Kleinman. 1998. Tumor-associated macrophages as targets for cancer therapy. J. Natl. Cancer Inst. 90:1583.
6. Van Rooijen N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Meth. 124:1.
7. Dougherty T.J., C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng. 1998. Photodynamic therapy. J. Natl Cancer Inst. 90:889.
8. Molpus K.L., M.R. Hamblin, I. Rizvi and T. Hasan. 2000. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Gynecol. Oncol. 76:397.
9. Hamblin M.R., M.D. Governatore, I. Rizvi and T. Hasan. 2000. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br. J. Cancer. 83:1544.
10. Demidova T.N. and M.R. Hamblin. 2004 Photodynamic therapy targeted to pathogens. Int. J. Immunopathol. Pharmacol. 17:245.
11. Demidova T.N. and M.R. Hamblin. 2004. Macrophage-targeted photodynamic therapy. Int. J. Immunopathol. Pharmacol. 17:117.
12. Hamblin M.R., J.L. Miller and B. Ortel. 2000. Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol 72:533.
13. Murakami T. and N. Yamada. 1996. Modification of macrophage function and effects on atherosclerosis. Curr. Op. Lipidol. 7:320.
14. Kaisho T. and S. Akira. 2000. Critical roles of toll-like receptors in host defense. Crit. Rev. Immunol. 20:393.
15. Kopp E.B. and R. Medzhitov. 1999 The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13.
16. Muzio M. and A. Mantovani. 2000. Toll-like receptors. Microbes Infect. 2:251.
17. Ingalls R.R., H. Heine, E. Lien, A. Yoshimura and D. Golenbock. 1999. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect. Dis. Clin. North Am. 13:341.
18. Brown G.D., RR. Taylor, D.M. Reid, J. A. Willment, D.L. Williams, L. Martinez-Pomares, S.Y. Wong and S. Gordon. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196:407.
19. Frantz S., L. Kobzik, Y.D. Kim, R. Fukazawa, R. Medzhitov, R.T. Lee and R.A. Kelly. 1999. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271.
20. Winston B.W., P.M. Krein, C. Mowat and Y. Huang. 1999. Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin. Invest. Med. 22:236.
21. Takata K., S. Horiuchi and Y. Morino. 1989. Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation. Biochim. Biophys. Acta. 984:273.
22. McHale A.P. and L. McHale. 1988. Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett. 41:315.
23. Osterud B. and E. Bjorklid. 2003. Role of monocytes in atherogenesis. Physiol. Rev. 83:1069.
24. Ashkenas J., M. Penman, E. Vasile, S. Acton, M. Freeman and M. Krieger. 1993. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 34:983.
25. Krieger M. 1992. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem. Sci. 17:141.
26. Haberland M.E. and A.M. Fogelman. 1985. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages. Proc. Natl. Acad. Sci. USA. 82:2693.
27. Yamada Y., T. Doi, T. Hamakubo and T. Kodama. 1998. Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. Life Sci. 54:628.
28. Mukhopadhyay A., B. Mukhopadhyay and S.K. Basu. 1995. Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery. FEBS Lett. 376:95.
29. Barbour S.E., C. Wong, D. Rabah, A. Kapur and A.D. Carter. 1998. Mature macrophage cell lines exhibit variable responses to LPS. Mol. Immunol. 35:977.
30. Frankenberger M. and H.W. Ziegler-Heitbrock. 1997. LPS tolerance in monocytes/macrophages: three 3′ cytosins are required in the DNA binding motif for detection of upregulated NF-kappa B p50 homodimers. Immunobiology 198:81.
31. Fujihara M., S. Wakamoto, T. Ito, M. Muroi, T. Suzuki, H. Ikeda and K. Ikebuchi. 2000. Lipopolysaccharide-triggered desensitization of TNF-alpha mRNA expression involves lack of phosphorylation of IkappaBalpha in a murine macrophage-like cell line, P388D1. J. Leukoc. Biol. 68:267.
32. Victor V.M. and M. De la Fuente. 2002. N-acetylcysteine improves in vitro the function of macrophages from mice with endotoxin-induced oxidative stress. Free Radic. Res. 36:33.
33. Hunt D.W., H.J. Jiang, J.G. Levy and A.H. Chan. 1995. Sensitivity of activated murine peritoneal macrophages to photodynamic killing with benzoporphyrin derivative. Photochem. Photobiol. 61:417.
34. Orlofsky A., RD. Somogyi, L.M. Weiss and M.B. Prystowsky. 1999. The murine antiapoptotic protein A1 is induced in inflammatory macrophages and constitutively expressed in neutrophils. J. Immunol. 163:412.
35. Kausalya S., R. Somogyi, A. Orlofsky and M.B. Prystowsky. 2001. Requirement of Al-a for bacillus Calmette-Guerin-mediated protection of macrophages against nitric oxide-induced apoptosis. J. Immunol. 166:4721.
36. Van Lenten B.J., A.M. Fogelman, J. Seager, E. Ribi, M.E. Haberland and P.A. Edwards. 1985. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J. Immunol. 134:3718.
37. Fitzgerald M.L., K.J. Moore, M.W. Freeman and G.L. Reed. 2000. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J. Immunol. 164:2692.
38. Geng Y.J. and G.K. Hansson. 1992. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89:1322.
39. Grewal T., E. Priceputu, J. Davignon and L. Bernier. 2001. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler. Thromb. Vasc. Biol 21:825.
40. Lougheed M. and U.P. Steinbrecher. 1996. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation. J. Biol. Chem. 271:11798.
41. Marsche G., R. Zimmermann, S. Horiuchi, N.N. Tandon, W. Sattler and E. Malle. 2003. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J. Biol. Chem. 278:47562.
42. Podrez E.A., M. Febbraio, N. Sheibani, D. Schmitt, R.L. Silverstein, D.P. Hajjar, P.A. Cohen, W.A. Frazier, H.F. Hoff and S.L. Hazen. 2000. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105:1095.
43. Podrez E.A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, B. Gugiu, P.L. Fox, H.F. Hoff, R.G. Salomon and S.L. Hazen. 2002. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277:38503.
44. Brown M.S., S.K. Basu, J.R. Falck, Y.K. Ho and J.L. Goldstein. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13:67.